Vol. 28 No. 1
January-February 2006

Two New CAs Join IUPAC

Two industrial companies from the United Kingdom have joined IUPAC as Company Associates. AstraZeneca R&D Charnwood and Syngenta will now take part, with more than 100 companies from around the world, in the work of the Committee on Chemistry and Industry to influence the IUPAC agenda.

The United Kingdom is one of the major hubs of AstraZeneca—one of the world’s leading pharmaceutical companies. The company’s Charnwood site is focused on finding new medicines for respiratory diseases such as asthma, chronic bronchitis, and emphysema (diseases often associated with smoking and for which new medicines are desperately needed) as well as inflammatory diseases such as rheumatoid and osteoarthritis.

Syngenta’s Jealott’s Hill, established in 1927, is a center of excellence for discovery and bio-performance research and is a key site for environmental sciences. It is the company’s largest research site, employing over 800 scientists and support staff. Jealott’s Hill houses the company’s main collection of hundreds of thousands of chemical compounds. Over 200 000 chemicals are added to the collection from a variety of sources each year. It is also the Syngenta global center for environmental sciences and works closely with Syngenta CTL to ensure all products are tested for safety in the environment.

AstraZeneca R&D Charnwood
Dr. John Dixon <[email protected]>
Vice President; Drug Discovery
<www.astrazeneca.com>

Syngenta
Jeollot’s Hill International Research Station
Bracknell, Berkshire
Dr. Paul Worthington <[email protected]>
<www.syngenta.co.uk/about/syngenta-jealotts-hill.asp>

www.iupac.org/links/ca.html